open access

Vol 94, No 11 (2023)
Research paper
Published online: 2023-06-09
Get Citation

The evaluation of serum brain-derived neurotrophic factor levels in pregnant women with hyperemesis gravidarum

Busra Demir Cendek1, Betul Tokgoz Cakir1, Rahime Bedir Fındık2, Mujde Can Ibanoglu1, Melahat Yildirim2, Huseyin Tugrul Celik1, Ayse Filiz Yavuz3
·
Pubmed: 37306163
·
Ginekol Pol 2023;94(11):913-917.
Affiliations
  1. Department of Biochemistry, Yuzuncu Yil Private Hospital, Ankara, Türkiye
  2. Department of Gynecology, T.C. Ministry of Health Ankara City Hospital, Ankara, Türkiye
  3. Department of Gynecology, T.C. Ministry of Health, Ankara City Hospital, Türkiye

open access

Vol 94, No 11 (2023)
ORIGINAL PAPERS Obstetrics
Published online: 2023-06-09

Abstract

Objectives: The aim of this study was to investigate the relationship between levels of brain-derived neurotrophic factor (BDNF), which is considered a cause of conditions such as depression and eating disorders, and hyperemesis gravidarum (HG).

Material and methods: This study was conducted as a prospective study at Ankara Ataturk Training and Research Hospital in the Department of Obstetrics and Gynecology. The study included 73 pregnant women with singleton pregnancies (32 pregnant women with HG and 41 pregnant women without hyperemesis). Serum BDNF levels were compared between the two groups.

Results: The mean age of the study group was 27.3 ± 3.5 years and the body mass index (BMI) was 22.4 ± 2.7 kg/m2. There is no statistically significant difference between the study group and the control group in terms of demographic data (p > 0.05). The pregnant women with HG were found to have significantly higher serum BDNF levels compared to the control group (349.1 ± 94.6 pg/mL vs 292. 3 ± 86.01, p = 0.009)

Conclusions: Serum BDNF levels that are low in psychiatric disorders such as depression or anxiety were found as high in pregnant women with HG.

Abstract

Objectives: The aim of this study was to investigate the relationship between levels of brain-derived neurotrophic factor (BDNF), which is considered a cause of conditions such as depression and eating disorders, and hyperemesis gravidarum (HG).

Material and methods: This study was conducted as a prospective study at Ankara Ataturk Training and Research Hospital in the Department of Obstetrics and Gynecology. The study included 73 pregnant women with singleton pregnancies (32 pregnant women with HG and 41 pregnant women without hyperemesis). Serum BDNF levels were compared between the two groups.

Results: The mean age of the study group was 27.3 ± 3.5 years and the body mass index (BMI) was 22.4 ± 2.7 kg/m2. There is no statistically significant difference between the study group and the control group in terms of demographic data (p > 0.05). The pregnant women with HG were found to have significantly higher serum BDNF levels compared to the control group (349.1 ± 94.6 pg/mL vs 292. 3 ± 86.01, p = 0.009)

Conclusions: Serum BDNF levels that are low in psychiatric disorders such as depression or anxiety were found as high in pregnant women with HG.

Get Citation

Keywords

hyperemesis gravidarum; psychological factors; brain-derived neurotrophic factor; pregnancy

About this article
Title

The evaluation of serum brain-derived neurotrophic factor levels in pregnant women with hyperemesis gravidarum

Journal

Ginekologia Polska

Issue

Vol 94, No 11 (2023)

Article type

Research paper

Pages

913-917

Published online

2023-06-09

Page views

328

Article views/downloads

258

DOI

10.5603/GP.a2023.0049

Pubmed

37306163

Bibliographic record

Ginekol Pol 2023;94(11):913-917.

Keywords

hyperemesis gravidarum
psychological factors
brain-derived neurotrophic factor
pregnancy

Authors

Busra Demir Cendek
Betul Tokgoz Cakir
Rahime Bedir Fındık
Mujde Can Ibanoglu
Melahat Yildirim
Huseyin Tugrul Celik
Ayse Filiz Yavuz

References (33)
  1. Ismail SK, Kenny L. Review on hyperemesis gravidarum. Best Pract Res Clin Gastroenterol. 2007; 21(5): 755–769.
  2. Verberg MFG, Gillott DJ, Al-Fardan N, et al. Hyperemesis gravidarum, a literature review. Hum Reprod Update. 2005; 11(5): 527–539.
  3. Munch S, Korst LM, Hernandez GD, et al. Health-related quality of life in women with nausea and vomiting of pregnancy: the importance of psychosocial context. J Perinatol. 2011; 31(1): 10–20.
  4. Mazzotta P, Stewart D, Atanackovic G, et al. Psychosocial morbidity among women with nausea and vomiting of pregnancy: prevalence and association with anti-emetic therapy. J Psychosom Obstet Gynaecol. 2000; 21(3): 129–136.
  5. Köken G, Yilmazer M, Cosar E, et al. Nausea and vomiting in early pregnancy: relationship with anxiety and depression. J Psychosom Obstet Gynaecol. 2008; 29(2): 91–95.
  6. Kim DR, Connolly KR, Cristancho P, et al. Psychiatric consultation of patients with hyperemesis gravidarum. Arch Womens Ment Health. 2009; 12(2): 61–67.
  7. Seifer DB, Feng Bo, Shelden RM, et al. Brain-derived neurotrophic factor: a novel human ovarian follicular protein. J Clin Endocrinol Metab. 2002; 87(2): 655–659.
  8. Larsen MH, Mikkelsen JD, Hay-Schmidt A, et al. Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment. J Psychiatr Res. 2010; 44(13): 808–816.
  9. Martinowich K, Manji H, Lu B. New insights into BDNF function in depression and anxiety. Nat Neurosci. 2007; 10(9): 1089–1093.
  10. Wu LM, Hu MH, Tong XH, et al. Chronic unpredictable stress decreases expression of brain-derived neurotrophic factor (BDNF) in mouse ovaries: relationship to oocytes developmental potential. PLoS One. 2012; 7(12): e52331.
  11. Zhao HF, Li Q, Li Y. Long-term ginsenoside administration prevents memory loss in aged female C57BL/6J mice by modulating the redox status and up-regulating the plasticity-related proteins in hippocampus. Neuroscience. 2011; 183: 189–202.
  12. Ege S, Bademkiran MH, Peker N, et al. Evaluation of catalase, myeloperoxidase and ferroxidase values in pregnant women with hyperemesis gravidarum. Ginekol Pol. 2019; 90(11): 651–655.
  13. Dmitrzak-Weglarz M, Skibinska M, Slopien A, et al. Serum neurotrophin concentrations in polish adolescent girls with anorexia nervosa. Neuropsychobiology. 2013; 67(1): 25–32.
  14. Zwipp J, Hass J, Schober I, et al. Serum brain-derived neurotrophic factor and cognitive functioning in underweight, weight-recovered and partially weight-recovered females with anorexia nervosa. Prog Neuropsychopharmacol Biol Psychiatry. 2014; 54: 163–169.
  15. Laske C, Banschbach S, Stransky E, et al. Increased BDNF serum concentration in fibromyalgia with or without depression or antidepressants. J Psychiatr Res. 2007; 41(7): 600–605.
  16. Murer MG, Boissiere F, Yan Q, et al. An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience. 1999; 88(4): 1015–1032.
  17. Lu B, Nagappan G, Guan X, et al. BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases. Nat Rev Neurosci. 2013; 14(6): 401–416.
  18. Blugeot A, Rivat C, Bouvier E, et al. Vulnerability to depression: from brain neuroplasticity to identification of biomarkers. J Neurosci. 2011; 31(36): 12889–12899.
  19. Scalzo P, Kümmer A, Bretas TL, et al. Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. J Neurol. 2010; 257(4): 540–545.
  20. Monteggia LM, Barrot M, Powell CM, et al. Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci USA. 2004; 101(29): 10827–10832.
  21. Berton O, McClung CA, Dileone RJ, et al. Essential role of BDNF in the mesolimbic dopamine pathway in social defeat stress. Science. 2006; 311(5762): 864–868.
  22. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006; 59(12): 1116–1127.
  23. Russo N, Russo M, Daino D, et al. Polycystic ovary syndrome: brain-derived neurotrophic factor (BDNF) plasma and follicular fluid levels. Gynecol Endocrinol. 2012; 28(4): 241–244.
  24. Sadeu JC, Doedée AM, Neal MS, et al. Neurotrophins (BDNF and NGF) in follicular fluid of women with different infertility diagnoses. Reprod Biomed Online. 2012; 24(2): 174–179.
  25. Boivin J, Takefman JE. Impact of the in-vitro fertilization process on emotional, physical and relational variables. Hum Reprod. 1996; 11(4): 903–907.
  26. Cousineau TM, Domar AD. Psychological impact of infertility. Best Pract Res Clin Obstet Gynaecol. 2007; 21(2): 293–308.
  27. Kotan Z, Sarandöl A, Saygın Ek, et al. Depression, neuroplasticity and neurotrophic factors. Current Approaches in Psychiatry. 2009; 1(1): 22–35.
  28. van der Meij A, Comijs HC, Dols A, et al. BDNF in late-life depression: effect of SSRI usage and interaction with childhood abuse. Psychoneuroendocrinology. 2014; 43: 81–89.
  29. Tan PC, Zaidi SN, Azmi N, et al. Depression, anxiety, stress and hyperemesis gravidarum: temporal and case controlled correlates. PLoS One. 2014; 9(3): e92036.
  30. Swallow BL, Lindow SW, Masson EA, et al. Psychological health in early pregnancy: relationship with nausea and vomiting. J Obstet Gynaecol. 2004; 24(1): 28–32.
  31. Simşek Y, Celik O, Yılmaz E, et al. Assessment of anxiety and depression levels of pregnant women with hyperemesis gravidarum in a case-control study. J Turk Ger Gynecol Assoc. 2012; 13(1): 32–36.
  32. Tsang IS, Katz VL, Wells SD. Maternal and fetal outcomes in hyperemesis gravidarum. Int J Gynaecol Obstet. 1996; 55(3): 231–235.
  33. Yoon CK, Chang MH, Lee DC. Wernicke-Korsakoff syndrome associated with hyperemesis gravidarum. Korean J Ophthalmol. 2005; 19(3): 239–242.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl